Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes

BACKGROUND: Recent clinical studies have shown that initial therapy with combined cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blockade and granulocyte-macrophage colony-stimulating factor (GM-CSF)-based immunotherapies can enhance the antitumor efficacy of this approach. A key unanswered qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peng, Chen, Fuchao, Zhou, Benhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037403/
https://www.ncbi.nlm.nih.gov/pubmed/30013322
http://dx.doi.org/10.2147/DDDT.S154258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037403/
https://www.ncbi.nlm.nih.gov/pubmed/30013322
http://dx.doi.org/10.2147/DDDT.S154258

Ejemplares similares